Editas Medicine (EDIT) Net Income towards Common Stockholders (2015 - 2025)
Editas Medicine (EDIT) recorded Net Income towards Common Stockholders of -$25.12 million in Q3 2025, compared with -$62.14 million a year earlier.
Powered by 
Analysis
Editas Medicine (EDIT) Net Income towards Common Stockholders (2015 - 2025) Analysis & Trends
On a TTM basis, Editas Medicine's Net Income towards Common Stockholders came in at -$199.84 million as of Sep 30, 2025; for FY2024, it came in at -$237.09 million.
- Across earlier years, Net Income towards Common Stockholders came in at -$153.22 million in FY2023, -$220.43 million in FY2022, -$192.5 million in FY2021 and -$115.98 million in FY2020.
- The Q3 2025 figure is the highest quarterly Net Income towards Common Stockholders since Q4 2023.
- Per Business Quant, the preceding three quarters came in at -$53.24 million (Q2 2025), -$76.09 million (Q1 2025) and -$45.4 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Editas Medicine | 244.35 Mn | -467.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -25.12 Mn |
| Jun 30, 2025 | -53.24 Mn |
| Mar 31, 2025 | -76.09 Mn |
| Dec 31, 2024 | -45.40 Mn |
| Sep 30, 2024 | -62.14 Mn |
| Jun 30, 2024 | -67.61 Mn |
| Mar 31, 2024 | -61.95 Mn |
| Dec 31, 2023 | -18.87 Mn |
| Sep 30, 2023 | -45.02 Mn |
| Jun 30, 2023 | -40.29 Mn |
| Mar 31, 2023 | -49.04 Mn |
| Dec 31, 2022 | -60.74 Mn |
| Sep 30, 2022 | -55.73 Mn |
| Jun 30, 2022 | -53.45 Mn |
| Mar 31, 2022 | -50.52 Mn |
| Dec 31, 2021 | -41.44 Mn |
| Sep 30, 2021 | -39.08 Mn |
| Jun 30, 2021 | -55.26 Mn |
| Mar 31, 2021 | -56.73 Mn |
| Dec 31, 2020 | -62.50 Mn |
API Access
Editas Medicine Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();